Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study-Reference-Cited by-同舟云学术

Major adverse cardiovascular events in non-valvular atrial fibrillation with chronic obstructive pulmonary disease: the ARAPACIS study

Published:2018-03-26 Issue:5 Volume:13 Page:651-660
ISSN:1828-0447
Container-title:Internal and Emergency Medicine
language:en
Short-container-title:Intern Emerg Med

Author:

Raparelli Valeria, ,Pastori Daniele,Pignataro Serena Francesca,Vestri Anna Rita,Pignatelli Pasquale,Cangemi Roberto,Proietti Marco,Davì Giovanni,Hiatt William Robert,Lip Gregory Yoke Hong,Corazza Gino Roberto,Perticone Francesco,Violi Francesco,Basili Stefania

Publisher

Springer Science and Business Media LLC

Subject

Emergency Medicine,Internal Medicine

Link

http://link.springer.com/article/10.1007/s11739-018-1835-9/fulltext.html

Reference34 articles.

1. Vestbo J, Hurd SS, Agusti AG et al (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187:347–365

2. Bousquet J, Dahl R, Khaltaev N (2007) Global alliance against chronic respiratory diseases. Eur Respir J 29:233–239

3. Ambrosino P, Lupoli R, Iervolino S, De Felice A, Pappone N, Storino A, Di Minno MND (2017) Clinical assessment of endothelial function in patients with chronic obstructive pulmonary disease: a systematic review with meta-analysis. Intern Emerg Med 12:877–885

4. Diez-Manglano J, Barquero-Romero J, Almagro P et al (2014) COPD patients with and without metabolic syndrome: clinical and functional differences. Intern Emerg Med 9:419–425

5. Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agusti A (2016) Chronic obstructive pulmonary disease and cardiac diseases: an urgent need for integrated care. Am J Respir Crit Care Med 194:1319–1336

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose azithromycin prophylaxis in patients with atrial fibrillation and chronic obstructive pulmonary disease;Internal and Emergency Medicine;2024-05-31

2. Risk of Death and Cardiovascular Events in Asian Patients With Atrial Fibrillation and Chronic Obstructive Pulmonary Disease: A Report From the Prospective APHRS Registry;Journal of the American Heart Association;2024-04-02

3. Machine Learning Approaches to Predict Major Adverse Cardiovascular Events in Atrial Fibrillation;Technologies;2024-01-23

4. The effects of medications for treating COPD and allied conditions on stroke: a population-based cohort study;npj Primary Care Respiratory Medicine;2022-01-17

5. A systematic literature review and meta-analysis on the impact of COPD on atrial fibrillation patient outcome;Heart & Lung;2022-01